Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV businessPoint-of-Care product revenue ...

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024New CM24 biomarkers data presented during the third quarter of ...

Q1 2024 361% growth in assets to $181.0 million following Solar Flow-Through Funds Ltd. Acquisition This news release constitutes a "designated news release" for the purposes of the Company's ...

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented during the third quarter of 2024 including two predicting serum biomarkers identif ...

The Company is required to file its Annual Filings all in accordance with IFRS within 120 days after the end of its completed financial year, such date being November 29, 2024 (the " Annual Filing ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Hello, everyone, and welcome all to Azul’s Third Quarter Earnings Call. My name is, Ed, and I will be your operator for today. This event ...

Q3 2024 Earnings Conference Call November 14, 2024 3:00 AM ETCompany ParticipantsBernd Sablowsky - Head of Investor ...

HIGHLIGHTS <li /> Sigma Lithium achieved strong operational performance at its Greentech industrial plant. </b ...

Learn about the best of the safest investments. Find out which investment categories offer the best protection for your principal and compare their advantages.

Group has invested €100 million in Europe’s first public solar asset-backed securitisation (ABS) led by German green tech ...